Most recent update: Thursday, March 26, 2020 - 15:09

Bariatric News - Cookies & privacy policy

You are here

Opinion & blogs

Bariatric News welcomes contributions from our readers. If you have a topic you'd like to talk about, or something you'd like to get off your chest, please get in touch.
10:22 12/05/14 | Owen Haskins | Editor in chief, Bariatric News

Just in case you missed any news last month, these were the 10 most read articles on in April 2014 including the latest research, product & industry news, policy news and more...

Metabolic Surgery – A randomized controlled trial

In reference to a recently published randomized controlled trial featured in the Lancet Diabetes - Endocrinology, co-author Professor Paul O'Brien, discusses the potential of metabolic surgery...(more)

STAMPEDE: 3 year results show surgical effectiveness

Three year outcomes from the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently (STAMPEDE) trial has shown that bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients...(more)

Loop duodeno-enterosomies offers new surgical options

Loop duodeno-enterosomies with sleeve gastrectomy can be safely performed and could ‘open new alternatives in bariatric surgery with the possibility for inter-individual adaptation’...(more)

Banding improves glycaemic control in overweight T2DM patients

Laparoscopic adjustable gastric band surgery in overweight people with type 2 diabetes improves glycaemic control, according to the results of an Australian randomised clinical trial...(more)

Cousin Biotech launches BIORING iPhone App

08:45 10/04/14 | Anonymous (not verified) |

In reference to a recently published randomized controlled trial featured in the Lancet Diabetes - Endocrinology , co-author Professor Paul O'Brien, discusses the potential of metabolic surgery...

The report of our recent randomized controlled trial in Lancet Diabetes - Endocrinology1  is a report of metabolic surgery. None of the patients in this trial was obese and we were not seeking weight loss as our primary endpoint. They all had type 2 diabetes and our primary aim was remission of diabetes. We believe this is the first RCT showing the effectiveness of pure metabolic surgery.

The term Metabolic Surgery is in the ascendency. Its rivals, Obesity Surgery and Bariatric Surgery are at risk. The term obesity has never been popular. It is a pejorative. It is a word that, to our lay and even some of our medical communities, carries a stigma, a problem reflecting a weakness of the person and to be solved by the person being stronger. The word bariatric is a resort to the Greek language to hide this unpleasantness.

But, more importantly, both terms are at risk because they are too narrow. They focus on obesity as the primary problem when we worry more about the diseases, the physical and psychosocial disabilities and the shortened length of life that are caused by obesity.  They focus on achieving weight loss as the primary aim when we want our patients to achieve better health, greater quality of life and a longer survival.

The term metabolic surgery has been used for more than 35 years, since Henry Buchwald and Richard Varco published their book of that name in 1978. They provided a broad definition of metabolic surgery - “the operative manipulation of a normal organ or organ system to achieve biological results for potential health gain”. It remains an appropriate definition today. Dr Buchwald went further to lock in the concept of metabolic surgery during the 1980s with a very fine series of studies of a small bowel bypass that aimed purely at the control of severe hypercholesterolemia. More recently, Francesco Rubino, Ricardo Cohen and others have investigated various gut modifications to control diabetes directly rather than through weight loss per se.

A metabolic disease may be defined as one where the processes, regulation or control of converting food to energy is abnormal. Some of the metabolic diseases are amenable to surgical treatment and thus form the basis for metabolic surgery. Obesity itself is a metabolic disease and, along with type 2 diabetes, is one of the two principal diseases that attract metabolic surgical treatments. Others include the dyslipidaemias, hypertension, the atheromatous coronary and peripheral vascular diseases, polycystic ovary syndrome, non-alcoholic steatohepatitis, obstructive sleep apnoea and number of common cancers.

10:10 08/04/14 | Owen Haskins | Editor in chief, Bariatric News

Just in case you missed any news last month, these were the 10 most read articles on in March 2014 including the latest research, product & industry news, policy news and clinical comment...

FXR receptor key to success of sleeve gastrectomy
The therapeutic value of vertical sleeve gastrectomy is not a result of the mechanical restriction of a smaller stomach but the result of increased circulating bile acids that are known to bind to the nuclear receptor farsenoid-X receptor (FXR), according to researchers from the University of Cincinnati (UC), the University of Gothenburg, Sweden, and Cincinnati Children's Hospital Medical Center...(more)

Exclusive: IFSO endorses Global Registry Pilot project
The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has endorsed the creation of a pilot project - The IFSO Global Registry Pilot (IGRP). The aims of the registry are to demonstrate that it is possible to merge and analyse bariatric and metabolic surgical data from different countries and centres, and to publish the data in a report to be released in time for the next IFSO World Congress to be held in Montreal, Canada, in August 2014...(more)

UK experts publish guide for commissioning Tier 3 services
Healthcare experts in the UK have published a clinical commissioning guide on weight loss services to assist Clinical Commissioning Groups (CCGs) in commissioning these services and reduce variation in access to weight-loss clinics across the country...(more)

Hormone causes hypoglycaemia after bypass surgery
Blocking the action of one of the gut hormones can correct post-meal hypoglycaemia in gastric bypass patients, according to researchers at the University of Cincinnati (UC). The study, published the journal Gastroenterology, is part of an ongoing effort by UC researchers to better understand glucose metabolism after weight-loss surgery...(more)

03:57 20/03/14 | Owen Haskins | Editor in chief, Bariatric News

The International Federation for the Surgery of Obesity and Metabolic Disorders has published its February 2014 newsletter, which is now available to download from the IFSO website.

Highlights in the latest issue include a message from IFSO’s president, Luigi Angrisani, who urges the presidents of all societies to participate in the Survey on bariatric surgery 2013. "It is a fundamental goal of our Federation to monitor and study the trend of Bariatric Surgery in the world. That’s why I expect a great participation from the Presidents of all the Societies. I’m sure that year by year, with the cooperation of all of us, this tool will be more and more precise and useful."

In an update from the European Chapter of IFSO, Chapter president, Professor Yuri Yashkov, highlighted some of the key issues that will be discussed at the 6th IFSO-EC meeting in Brussels including: new technical opportunities, optimal approaches for surgical treatment of Diabetes Mellitus, surgical options for children and adolescents, for the patients with BMI <35 and interdisciplinary approaches to bariatric patients.

In addition, professor Luc Lemmens, President of the 6th IFSO-EC Congress, announces that the 2nd European Obesity Medico-Surgical Workshop will be a formal satellite of IFSO EC 2014 jointly organized by IFSO EC and EASO. It will be a one day workshop where surgeons and endocrinologist will have the opportunity to discuss items of common interest.

Professor Wej-Jei Lee, President of APC, reported on the success of the first meeting of the Gulf Obesity and Metabolic Surgery Society (GOSS). He also announced that the next IFSO-APC meeting will take place in Seoul, Korea in 2015: "The Korean Society for Metabolic and Bariatric Society (KSMBS) joined the Asia-Pacific Chapter of IFSO last year,  and it won the bid to host the next meeting. The dates have been set, so mark April 9-11, 2015 on your calendar for what we trust will be a great meeting in an exciting city."

Jaime Ponce, President of the North American Chapter, highlighted the successful inaugural ObesityWeek meeting that was attended by more than 4,700 surgeons, nurses, clinicians, policymakers, integrated health professionals, scientists and researchers, including over 700 international attendees.

Dr Natan Zundel, President of the Latin American Chapter, reports that IFSO Latin American Chapter has a new website:

Finally, there are also updates on forthcoming IFSO World Congress meeting from Michel Gagner President of the IXX IFSO Congress, Karl Miller President of the XX IFSO Congress, and Ricardo Cohen, President of the XXI IFSO Congress.